Review decisions
Showing 230 results of 2299 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1687801209635
Product Type: Drug
Control Number: 268412
DIN(s): 02537745
Manufacturer: Rhythm Pharmaceuticals Inc.
Submission Type: New Drug Submission - Priority Review
Date Filed / Submission Date: 2022-10-04
Decision / Authorization Date: 2023-05-05
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1686686460648
Product Type: Drug
Control Number: 264612
DIN(s): 02495155, 02520893
Manufacturer: AbbVie Corporation
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-05-27
Decision / Authorization Date: 2023-05-02
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1684156979784
Product Type: Drug
Control Number: 264318
DIN(s): 02456869
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-05-16
Decision / Authorization Date: 2023-04-19
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1725029128529
Product Type: Drug
Control Number: 275236
DIN(s): 02545713, 02545721
Manufacturer: Sanofi-Aventis Canada Inc.
Submission Type: New Drug Submission (New Active Substance) - Priority Review
Date Filed / Submission Date: 2023-05-12
Issued / Original Publication Date: 2024-08-30
Decision / Authorization Date: 2024-02-28
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1685724874375
Product Type: Drug
Control Number: 262756
DIN(s): 02489597
Manufacturer: Amgen Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-03-24
Decision / Authorization Date: 2023-03-21
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1683309818342
DIN(s): 00004723, 02415275
Issued / Original Publication Date: 2023-05-10
Updated Date: 2023-05-10
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1683810710858
Product Type: Drug
Control Number: 268311
DIN(s): 02470365, 02492504, 02510049, 02524252, 02526190
Manufacturer: Sanofi-Aventis Canada Inc.
Submission Type: Supplement to a New Drug Submission - Priority Review
Date Filed / Submission Date: 2022-10-03
Decision / Authorization Date: 2023-05-01
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1683828447298
Product Type: Drug
Control Number: 255584
Manufacturer: Merck Canada Inc.
Submission Type: New Drug Submission (New Active Substance) (COVID-19)
Date Filed / Submission Date: 2021-08-20
Decision / Authorization Date: 2023-04-26
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1692038706127
Product Type: Drug
Control Number: 263826
DIN(s): 02537702
Manufacturer: AbbVie Corporation
Submission Type: New Drug Submission
Date Filed / Submission Date: 2022-04-29
Decision / Authorization Date: 2023-05-03
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1692293386336
Product Type: Drug
Control Number: 255507
DIN(s): 02537435, 02537443
Manufacturer: Idorsia Pharmaceuticals Ltd
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-08-25
Decision / Authorization Date: 2023-04-28